Author

J. Taubmann

Institutions: Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen

Observed institutions: University of Batna 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Chinese Academy of Medical Sciences & Peking Union Medical College, Ghent University Hospital, Ghent University, Universitätsklinikum Erlangen, VIB-UGent Center for Inflammation Research, Ospedale Policlinico San Martino, University of Genoa

OpenAlex ID: A5000906342

Op0141 Long Term Safety and Efficacy of Car-t Cell Treatment in Refractory Systemic Lupus Erythematosus - Data From the First Seven Patients

2023 · J. Taubmann, F. Müller, et al. · Annals of the Rheumatic Diseases · 18

Op0027 Long-term Safety and Efficacy of Car-t Cell Treatment in Severe and Treatment Refractory Autoimmune Disease

2024 · J. Taubmann, F. Müller, et al. · Annals of the Rheumatic Diseases · 9

Ab0816 Treatment of a Patient With Severe Diffuse Systemic Sclerosis (ssc) Using Cd19-targeting Car-t-cells

2023 · C. Bergmann, F. Müller, et al. · Annals of the Rheumatic Diseases · 6

Pos0062 Safety and Preliminary Efficacy of Cd19 Car T-cell Treatment in Rheumatic Disease – Data From the Phase I/ii Castle Basket Study

2025 · M. Hagen, A. Wirsching, et al. · Annals of the Rheumatic Diseases · 4

Pos1238 First Evidence for Efficacy of Car-t Cell Treatment in Refractory Antisynthetase Syndrome

2023 · J. Taubmann, F. Müller, et al. · Annals of the Rheumatic Diseases · 4

OP0320 EFFICACY OF CD19-TARGETING CAR T CELL TREATMENT IN PATIENTS WITH DIFFUSE SYSTEMIC SCLEROSIS (dSSc) – AN OPEN LABEL, SINGLE-CENTER PILOT STUDY

2024 · J. Auth, F. Müller, et al. · Annals of the Rheumatic Diseases · 3

Pos0464 Serum Proteomic Analysis Identifies Markers Associated With Anti-cd19 Car T Therapeutic Response in Autoimmune Diseases

2024 · J. Chou, R. Grieshaber-Bouyer, et al. · Annals of the Rheumatic Diseases · 2

Pos0900 Automatic Scoring of Erosion, Synovitis and Bone Oedema in Rheumatoid Arthritis Using Deep Learning on Hand Magnetic Resonance Imaging

2023 · M. Schlereth, A. Kleyer, et al. · Annals of the Rheumatic Diseases · 2

Pos0946 Immunocleansing-associated Toxicity Syndrome (icats) in Car T-cell Treated Patients With Autoimmune Disease

2025 · M. Hagen, F. Müller, et al. · Annals of the Rheumatic Diseases · 1

Pos0340 Effects of Car-t Cell Treatment on B Cell Immunity in Systemic Autoimmune Diseases

2024 · L. Bucci, T. Rothe, et al. · Annals of the Rheumatic Diseases · 1

Pos0798 B Cell Reconstitution in Sle Patients After Car-t Cell Therapy Is Marked by a Naïve Phenotype and Reduction of Extrafollicular Immune Responses

2025 · D.M. Nöthling, L. Bucci, et al. · Annals of the Rheumatic Diseases

Pos1209 Effects of Cd19 Car T-cell Therapy on Quality of Life and Direct Health Care Costs in Systemic Lupus Erythematosus

2025 · J. Taubmann, M. Hagen, et al. · Annals of the Rheumatic Diseases

Abs0123 Distinct Molecular Responses to Cd19 Car-t Cell Therapy Versus Standard Pharmacotherapy in Systemic Lupus Erythematosus

2025 · P. Garantziotis, L. Beretta, et al. · Annals of the Rheumatic Diseases

POS0260 LONG-TERM HUMORAL RESPONSE TO SARS-CoV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASE

2022 · K. Tascilar, D. Simon, et al. · Annals of the Rheumatic Diseases

Works count: 14

Citation count: 50

H-index: 4

I10-index: 1